Keyphrases
Early Breast Cancer
60%
Breast Cancer
45%
Chemotherapy
42%
Sarcopenia
38%
Meta-analysis
38%
Body Composition
36%
Metastatic Breast Cancer
31%
Adult Cancer
25%
Adverse Events
23%
Systematic Meta-analysis
22%
Skeletal muscle Index
22%
Confidence Interval
21%
Human Epidermal Growth Factor Receptor 2 (HER2)
20%
Breast Cancer Patients
17%
Overall Survival
17%
Skeletal muscle Density
17%
Endocrine Treatment
16%
Treatment Toxicity
16%
Geriatric Assessment
16%
Body Mass Index
16%
Skeletal muscle
15%
Comorbidity
15%
Weight Gain
15%
In Cancer
14%
Adjuvant Chemotherapy
13%
Hormone Receptor-positive
13%
Hazard Ratio
13%
Relative Risk
13%
Older Patients
12%
Quality of Life
12%
Older Women
12%
Taxane-based Chemotherapy
12%
Anthracyclines
12%
Frailty
11%
Cancer Patients
11%
Older Adults
11%
Skeletal muscle Gauge
11%
Myosteatosis
11%
Dose Reduction
11%
Chemotherapy Regimen
10%
Tumor
10%
Hospitalization
10%
Hormone Receptor
10%
Anthracycline-based Chemotherapy
9%
Very Severe
9%
HER2-positive
9%
Breast Cancer Recurrence
9%
Black Women
9%
Clinical Trials
8%
Physical Function
8%
Medicine and Dentistry
Breast Cancer
100%
Skeletal Muscle
40%
Malignant Neoplasm
39%
Sarcopenia
37%
Systematic Review
34%
Meta-Analysis
34%
Hormone Receptor
21%
Metastatic Breast Cancer
21%
Hormone Therapy
19%
Overall Survival
17%
Comorbidity
14%
Quality of Life
14%
Adverse Event
13%
Adipose Tissue
13%
Neoplasm
12%
Metastatic Carcinoma
12%
Frailty
11%
Hazard Ratio
11%
Oncology
11%
Cancer Diagnosis
11%
Geriatric Assessment
10%
Body Mass Index
10%
Solid Malignant Neoplasm
9%
Recurrent Disease
8%
Computer Assisted Tomography
8%
Alpelisib
8%
Advanced Cancer
8%
Clinical Trial
7%
Patient-Reported Outcome
7%
Gamma Urogastrone
6%
Odds Ratio
6%
Patient Characteristics
6%
Epidermal Growth Factor Receptor 2
6%
Anthracycline
6%
Adjuvant Chemotherapy
6%
Randomized Controlled Trial
5%
Breast Carcinoma
5%
Tumor Progression
5%
Intraductal Carcinoma
5%
Diseases
5%
Clinician
5%
Prospective Study
5%
Adjuvant Therapy
5%